Live feed
Filing
SC 13D
SC 13D0001104659-17-070511·Avalo Therapeutics, Inc.
Schedule 13D ownership disclosure
CERECOR INC
Security class unavailable · CUSIP: 15671L109
Event date: 2017-11-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,592,458
- Percent of class
- 8.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-17-070511
- Form type
- SC 13D
- Filer
- Avalo Therapeutics, Inc.
- CIK
- CIK 1534120
- Filed
- Nov 27, 2017
- Reporting period
- Nov 17, 2017
- Description
- Schedule 13D beneficial ownership